Biểu đồ giá cổ phiếu IKT
IKT Cổ tức
Inhibikase Therapeutics Inc
$2.33
-3.31%
$-0.08
Khi đóng cửa: Sep 10, 16:00:00 GMT-4
$2.33
0%
$0
Phiên sau giờ: Sep 10, 20:00:00 GMT-4
Quay lại
Inhibikase Therapeutics Inc (IKT) Cổ tức
Thống kê chính
Giá đóng cửa trước
$2.41
Giá mở cửa
$2.37
Phạm vi ngày
$2.32 - $2.37
Phạm vi 52 tuần
$1.33 - $2.61
Khối lượng
332.3K
Khối lượng trung bình
737.2K
Tỷ suất cổ tức
--
EPS (TTM)
-0.50
Vốn hóa thị trường
$365.8M
IKT là gì?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
